Clinical Trial Update: Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing irinotecan plus capecitabine versus cisplatin plus capecitabine in patients with gastric cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED